SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-040355
Filing Date
2019-11-05
Accepted
2019-11-05 16:02:49
Documents
60
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q derm-10q_20190930.htm 10-Q 2577445
2 EX-10.1 derm-ex101_377.htm EX-10.1 71084
3 EX-31.1 derm-ex311_6.htm EX-31.1 16926
4 EX-31.2 derm-ex312_9.htm EX-31.2 17556
5 EX-32.1 derm-ex321_7.htm EX-32.1 5779
6 EX-32.2 derm-ex322_8.htm EX-32.2 6407
  Complete submission text file 0001564590-19-040355.txt   7184598

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT derm-20190930.xml EX-101.INS 1230479
8 XBRL TAXONOMY EXTENSION SCHEMA derm-20190930.xsd EX-101.SCH 53742
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE derm-20190930_cal.xml EX-101.CAL 57160
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE derm-20190930_def.xml EX-101.DEF 201587
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE derm-20190930_lab.xml EX-101.LAB 433493
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE derm-20190930_pre.xml EX-101.PRE 326660
Mailing Address 275 MIDDLEFIELD ROAD SUITE 150 MENLO PARK CA 94025
Business Address 275 MIDDLEFIELD ROAD SUITE 150 MENLO PARK CA 94025 650 421 7200
Dermira, Inc. (Filer) CIK: 0001557883 (see all company filings)

IRS No.: 273267680 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36668 | Film No.: 191193225
SIC: 2834 Pharmaceutical Preparations